Share of adolescent girls vaccinated against human papillomavirus in South Africa

South Africa: Share of adolescent girls vaccinated against human papillomavirus was 44.0% in 2024. ◆ Volatile

Latest (2024)
44.0%
Change on year
up 120.0%
World rank
60th
of 74 countries
All-time high
71.0%
in 2021
All-time low
9.0%
in 2018
Years of data
7
2018–2024

Share of adolescent girls vaccinated against human papillomavirus in South Africa, 2018–2024

0204060802018202120242018: 9 %2019: 28 %2020: 61 %2021: 71 %2022: 54 %2023: 20 %2024: 44 %

Source: WHO & UNICEF (2025) – processed by Our World in Data. Measured in %.

Analysis

In 2024, share of adolescent girls vaccinated against human papillomavirus in South Africa stood at 44.0%.

The figure is up 120.0% on the previous year and up 388.9% over ten years.

South Africa ranks 60th of 74 countries on this measure, in the bottom quarter.

Share of adolescent girls vaccinated against human papillomavirus in South Africa, year by year

Annual values for Share of adolescent girls vaccinated against human papillomavirus in South Africa, 2018 to 2024.
Year % Change
2018 9.0%
2019 28.0% +211.1%
2020 61.0% +117.9%
2021 71.0% +16.4%
2022 54.0% -23.9%
2023 20.0% -63.0%
2024 44.0% +120.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 18.5% 9.0% 28.0% 2
2020s 50.0% 20.0% 71.0% 5

Countries ranked near South Africa

  1. 57 Guyana 48.0% compare
  2. 57 Micronesia, Federated States of 48.0% compare
  3. 59 France 45.0% compare
  4. 61 Palau 43.0% compare
  5. 62 Armenia 41.0% compare
  6. 63 Zimbabwe 39.0% compare

See the full ranking of 74 places →

More health data for South Africa

All data for South Africa →

Frequently asked questions

What is share of adolescent girls vaccinated against human papillomavirus in South Africa?
Share of adolescent girls vaccinated against human papillomavirus in South Africa was 44.0% in 2024, according to WHO & UNICEF (2025) – processed by Our World in Data.
What is the highest share of adolescent girls vaccinated against human papillomavirus recorded in South Africa?
The highest recorded value was 71.0% in 2021.
What is the lowest share of adolescent girls vaccinated against human papillomavirus recorded in South Africa?
The lowest recorded value was 9.0% in 2018.
How does South Africa rank for share of adolescent girls vaccinated against human papillomavirus?
South Africa ranks 60th out of 74 countries with data for 2024.
Is share of adolescent girls vaccinated against human papillomavirus rising or falling in South Africa?
Over the last ten years it is up 388.9%. The long-run trend across the full record is volatile.
Where does this South Africa data come from?
The figures come from WHO & UNICEF (2025) – processed by Our World in Data, published as part of Share of adolescent girls vaccinated against human papillomavirus. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of adolescent girls vaccinated against human papillomavirus in South Africa. Statizoid, drawing on WHO & UNICEF (2025) – processed by Our World in Data. Retrieved 05 September 2026, from https://health.statizoid.com/stat/coverage-of-the-human-papillomavirus-vaccine/south-africa/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/coverage-of-the-human-papillomavirus-vaccine/south-africa/">Share of adolescent girls vaccinated against human papillomavirus in South Africa</a> — Statizoid

About this data

Indicator
Share of adolescent girls vaccinated against human papillomavirus
Unit
%
Source
WHO & UNICEF (2025) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
74 places, 719 data points, 2010–2024
Last refreshed

Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.